NASDAQ:IRMD iRadimed Q3 2026 Earnings Date & Estimates $85.82 0.00 (0.00%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$85.76 -0.06 (-0.08%) As of 10/23/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. iRadimed is estimated to report Q3 2026 earnings on Friday, October 30, 2026, before market opens. The conference call is scheduled for 11:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateOctober 30, 2026TimeBefore Market OpensConference Call11:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from iRadimed in Q3 2026iRadimed is expected to post earnings of $0.55 per share on revenue of $23.47 million. In the same quarter a year earlier iRadimed reported $0.47 per share on revenue of $21.20 million. iRadimed last reported on July 31, 2026, posting $0.46 per share and beating the $0.44 consensus estimate. iRadimed has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.55Expected Revenue$23.47 millionPrior-Year EPS$0.47Prior-Year Revenue$21.20 millionExpected EPS Growth+17.0%Expected Revenue Growth+10.7%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.46 (Beat by +$0.02)Last Quarter Revenue$20.47 millionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report iRadimed Q3 2026 Earnings FAQ When does iRadimed report Q3 2026 earnings? iRadimed (NASDAQ:IRMD) is estimated to report Q3 2026 earnings on Friday, October 30, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is iRadimed's Q3 2026 earnings call? iRadimed's Q3 2026 earnings conference call is scheduled for Friday, October 30, 2026 at 11:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for iRadimed? Analysts expect iRadimed to post earnings of $0.55 per share for Q3 2026. How much revenue is iRadimed expected to report? The consensus revenue estimate for iRadimed is $23.47 million for Q3 2026. iRadimed Earnings HeadlinesPeople to Know in Healthcare: Roger Susi, IradimedOctober 23 at 5:51 PM | bizjournals.comIRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026October 23 at 8:30 AM | globenewswire.comDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December. | Porter & Company (Ad)IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities ConferenceSeptember 23, 2026 | globenewswire.comNeedham Initiates IRadimed at HoldSeptember 22, 2026 | marketscreener.comMiRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100September 4, 2026 | gurufocus.comSee More iRadimed Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like iRadimed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on iRadimed and other key companies, straight to your email. Email Address About iRadimediRadimed (NASDAQ:IRMD) (NASDAQ: IRMD) develops, manufactures and sells medical devices designed for use during magnetic resonance imaging (MRI) procedures. The company focuses on solutions that allow clinicians to deliver intravenous medications and monitor patients safely while they are in or near an MRI scanner. Its principal products include the MRidium MRI-compatible infusion pump systems, which are designed to administer intravenous fluids and medications without interfering with MRI operations. iRadimed also offers MRI-compatible patient monitoring systems for tracking vital signs during procedures, along with related accessories, disposables and support services. Founded in 1992 and headquartered in Winter Park, Florida, iRadimed serves hospitals and other healthcare providers in the United States and international markets through direct sales and distributors. Its products are intended for applications including anesthesia, sedation, critical care and other situations in which patients require continuous medication delivery or monitoring during MRI examinations.View iRadimed ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a PipelineNewmont’s Record Quarter Shows Why Gold’s Floor Is the Real StoryLockheed Martin’s Record $292 Billion Backlog Comes With a Delivery TestCan Planet Fitness Get Its Growth Back in Shape?Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs Upcoming Earnings Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Coca Cola Femsa (10/27/2026)Baker Hughes (10/27/2026)ONEOK (10/27/2026)Robinhood Markets (10/27/2026)HSBC (10/27/2026)S&P Global (10/27/2026)Visa (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
